VOR – vor biopharma inc. (US:NASDAQ)
Stock Stats
News
Vor Biopharma (VOR) was upgraded by Wall Street Zen from "strong sell"
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Vor Biopharma (VOR) had its price target raised by Wedbush from $9.00 to $15.00. They now have a "neutral" rating on the stock.
Vor Biopharma (VOR) was upgraded by Jefferies Financial Group Inc. to "strong-buy".
Vor Biopharma (VOR) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating and a $50.00 price target on the stock.
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Form 4 Vor Biopharma Inc. For: Apr 08 Filed by: Kolchinsky Peter
Form 3 Vor Biopharma Inc. For: Apr 01 Filed by: Sokolove Jeremy Brett
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Form 4 Vor Biopharma Inc. For: Apr 02 Filed by: Kolchinsky Peter
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.